CC vs EFX · P/E 72, rev $1.36B vs P/E 54, rev $5.68B
Chemours Co (CC) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
CC currently screens at market cap $1.94B and trailing P/E 71.8. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the CC and EFX stock pages for the full models.
Not investment advice.